WEBSITE BSE:532851 NSE: INSECTCID Inc. Year: 1996 Industry: Pesticides & Agrochemicals
Last updated: 15:43
Insecticides (India) Ltd is an agrochemicals company in India which is engaged inside the production activities of agro chemicals, insecticides and technical merchandise for agriculture functions. Its segments comprises Formulated Pesticides and Technical Pesticides. The Formulated Pesticides segment consists of pesticides, herbicides, fungicides and plant growth regulators. The Technical Pesticides are the simple active ingredients used for making formulations so that they can be used by the farmers and/or customers. Its merchandise consist of...Read More
Insecticides (India) Ltd is an agrochemicals company in India which is engaged inside the production activities of agro chemicals, insecticides and technical merchandise for agriculture functions. Its segments comprises Formulated Pesticides and Technical Pesticides. The Formulated Pesticides segment consists of pesticides, herbicides, fungicides and plant growth regulators. The Technical Pesticides are the simple active ingredients used for making formulations so that they can be used by the farmers and/or customers. Its merchandise consist of formulations, technicals and household merchandise. It caters to both domestic and international markets. The Company's merchandise are to be had in over 120 formulations and approximately 20 technicals. The Company gives a range of merchandise, including LETHAL SUPER 550, LETHAL SUPER 505, NUVAN, LETHAL, LETHAL 50, VICTOR, MONOCIL, THIMET, SHARP, BRAVO 2500, LETHAL TC, DICHLORVOS, BUPROFEZIN, LETHAL WOODCARE (RTU) and LETHAL ADVANCE. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1749 Cr.
Stock P/E 12.3
P/B 1.4
Current Price ₹601.1
Book Value ₹ 417
Face Value 10
52W High ₹1096.3
Dividend Yield 0.33%
52W Low ₹ 531.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 696 | 358 | 273 | 657 | 627 | 358 | 359 | 691 | 638 | 385 |
| Other Income | -0 | 1 | 5 | 2 | 2 | 0 | 3 | 4 | 3 | 1 |
| Total Income | 696 | 359 | 277 | 659 | 628 | 358 | 362 | 695 | 640 | 386 |
| Total Expenditure | 614 | 332 | 264 | 585 | 537 | 327 | 330 | 607 | 548 | 358 |
| Operating Profit | 82 | 27 | 13 | 75 | 91 | 31 | 31 | 88 | 92 | 28 |
| Interest | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 |
| Depreciation | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 72 | 17 | 4 | 66 | 82 | 22 | 22 | 77 | 79 | 14 |
| Provision for Tax | 19 | 5 | -4 | 17 | 21 | 5 | 8 | 19 | 20 | 4 |
| Profit After Tax | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 |
| Adjusted Earnings Per Share | 18 | 4.1 | 2.5 | 16.7 | 20.7 | 6 | 4.8 | 20 | 20.3 | 3.6 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 965 | 988 | 994 | 1073 | 1194 | 1363 | 1420 | 1504 | 1801 | 1966 | 2000 | 2073 |
| Other Income | 1 | 1 | 7 | 3 | 1 | 3 | 8 | 4 | 1 | 9 | 7 | 11 |
| Total Income | 966 | 989 | 1001 | 1076 | 1194 | 1366 | 1428 | 1508 | 1803 | 1976 | 2007 | 2083 |
| Total Expenditure | 854 | 896 | 883 | 925 | 1006 | 1207 | 1268 | 1334 | 1679 | 1804 | 1779 | 1843 |
| Operating Profit | 112 | 93 | 118 | 151 | 188 | 158 | 160 | 174 | 123 | 172 | 228 | 239 |
| Interest | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 15 |
| Depreciation | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 32 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -10 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 64 | 50 | 82 | 118 | 153 | 110 | 120 | 141 | 84 | 132 | 193 | 192 |
| Provision for Tax | 9 | 11 | 23 | 34 | 31 | 24 | 26 | 34 | 21 | 30 | 51 | 51 |
| Profit After Tax | 55 | 40 | 59 | 84 | 122 | 86 | 94 | 107 | 63 | 102 | 142 | 141 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 55 | 40 | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 141 |
| Adjusted Earnings Per Share | 19.2 | 12.8 | 19.3 | 27.2 | 39.6 | 28 | 30.3 | 36.3 | 21.4 | 34.5 | 48.8 | 48.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 2% | 10% | 8% | 8% |
| Operating Profit CAGR | 33% | 9% | 8% | 7% |
| PAT CAGR | 39% | 10% | 11% | 10% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | -0% | 13% | 10% |
| ROE Average | 14% | 10% | 11% | 14% |
| ROCE Average | 18% | 13% | 14% | 16% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 291 | 409 | 464 | 548 | 662 | 732 | 820 | 870 | 918 | 1012 | 1085 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 54 | 28 | 15 | 8 | 1 | 2 | 2 | 2 | 2 | 29 | 23 |
| Other Non-Current Liabilities | 20 | 24 | 26 | 45 | 52 | 44 | 50 | 53 | 38 | 47 | 13 |
| Total Current Liabilities | 556 | 475 | 489 | 425 | 674 | 539 | 585 | 508 | 760 | 664 | 833 |
| Total Liabilities | 920 | 936 | 995 | 1026 | 1388 | 1317 | 1457 | 1432 | 1718 | 1752 | 1954 |
| Fixed Assets | 205 | 198 | 185 | 232 | 240 | 239 | 239 | 253 | 262 | 283 | 279 |
| Other Non-Current Assets | 52 | 62 | 96 | 75 | 86 | 100 | 133 | 176 | 224 | 217 | 194 |
| Total Current Assets | 662 | 675 | 715 | 719 | 1062 | 978 | 1086 | 1003 | 1232 | 1252 | 1481 |
| Total Assets | 920 | 936 | 995 | 1026 | 1388 | 1317 | 1457 | 1432 | 1718 | 1752 | 1954 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 12 | 9 | 7 | 7 | 20 | 9 | 68 | 6 | 36 | 19 | 61 |
| Cash Flow from Operating Activities | -6 | 86 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 |
| Cash Flow from Investing Activities | -34 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 |
| Cash Flow from Financing Activities | 36 | -64 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 |
| Net Cash Inflow / Outflow | -4 | 4 | -0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 |
| Closing Cash & Cash Equivalent | 9 | 12 | 7 | 20 | 9 | 68 | 6 | 36 | 19 | 61 | 56 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 19.22 | 12.77 | 19.26 | 27.19 | 39.62 | 28.03 | 30.29 | 36.3 | 21.36 | 34.49 | 48.81 |
| CEPS(Rs) | 24.34 | 18.08 | 24.32 | 32.59 | 45.83 | 35.52 | 38.25 | 45.2 | 30.18 | 44.37 | 58.83 |
| DPS(Rs) | 2.5 | 2 | 2 | 2 | 2 | 6 | 2 | 3 | 3 | 3 | 2 |
| Book NAV/Share(Rs) | 101.12 | 131.38 | 149.83 | 176.71 | 213.54 | 236.03 | 264.62 | 293.81 | 310.26 | 341.82 | 372.74 |
| Core EBITDA Margin(%) | 10.75 | 8.78 | 10.35 | 12.13 | 14.31 | 10.31 | 9.6 | 10.28 | 6.14 | 7.39 | 9.91 |
| EBIT Margin(%) | 9.4 | 7.28 | 9.5 | 10.99 | 12.86 | 8.89 | 7.95 | 8.96 | 4.9 | 6.5 | 8.95 |
| Pre Tax Margin(%) | 6.19 | 4.8 | 7.62 | 9.69 | 11.7 | 7.31 | 7.53 | 8.56 | 4.22 | 6.01 | 8.64 |
| PAT Margin (%) | 5.31 | 3.78 | 5.52 | 6.89 | 9.36 | 5.69 | 5.92 | 6.51 | 3.18 | 4.65 | 6.37 |
| Cash Profit Margin (%) | 6.73 | 5.35 | 7.01 | 8.29 | 10.87 | 7.29 | 7.47 | 8.1 | 4.5 | 5.98 | 7.67 |
| ROA(%) | 9.78 | 4.26 | 6.15 | 8.31 | 10.14 | 6.36 | 6.77 | 7.44 | 4.01 | 5.88 | 7.66 |
| ROE(%) | 28.42 | 11.38 | 13.63 | 16.59 | 20.24 | 12.35 | 12.1 | 12.71 | 7.07 | 10.58 | 13.55 |
| ROCE(%) | 26.91 | 12.46 | 15.55 | 19.66 | 20.65 | 14.24 | 13.74 | 16.13 | 9.75 | 13.15 | 17.52 |
| Receivable days | 35.35 | 65.22 | 71.11 | 66.83 | 66.86 | 68.11 | 66.07 | 60.07 | 53.79 | 49.29 | 55.78 |
| Inventory Days | 86.22 | 129.21 | 131.65 | 124.71 | 155.24 | 147.84 | 135.75 | 142.71 | 137.14 | 138.76 | 138.53 |
| Payable days | 79.6 | 126.29 | 111.63 | 116.21 | 131.55 | 102.55 | 114.01 | 124.25 | 110.52 | 118.58 | 140.28 |
| PER(x) | 15.98 | 16.27 | 18.39 | 16.88 | 11.1 | 7.45 | 10.43 | 11.27 | 21.88 | 14.17 | 12.13 |
| Price/Book(x) | 3.04 | 1.58 | 2.36 | 2.6 | 2.06 | 0.88 | 1.19 | 1.39 | 1.51 | 1.43 | 1.59 |
| Dividend Yield(%) | 0.36 | 0.64 | 0.38 | 0.29 | 0.3 | 1.92 | 0.42 | 0.49 | 0.64 | 0.61 | 0.34 |
| EV/Net Sales(x) | 1.23 | 0.85 | 1.33 | 1.41 | 1.39 | 0.56 | 0.7 | 0.81 | 0.85 | 0.75 | 0.88 |
| EV/Core EBITDA(x) | 10.65 | 9.04 | 11.21 | 10.04 | 8.83 | 4.8 | 6.2 | 7.04 | 12.36 | 8.55 | 7.73 |
| Net Sales Growth(%) | 266.02 | 2.39 | 0.6 | 7.95 | 11.21 | 14.22 | 4.18 | 5.9 | 19.77 | 9.16 | 1.71 |
| EBIT Growth(%) | 257.38 | -21.4 | 33.97 | 31.13 | 25.53 | -20.14 | -6.1 | 17.32 | -34.27 | 46.77 | 39.82 |
| PAT Growth(%) | 162.21 | -27.82 | 50.06 | 41.37 | 45.77 | -29.71 | 9.14 | 14.4 | -41.16 | 61.48 | 39.13 |
| EPS Growth(%) | 162.2 | -33.56 | 50.82 | 41.19 | 45.7 | -29.23 | 8.04 | 19.83 | -41.16 | 61.48 | 41.52 |
| Debt/Equity(x) | 1.11 | 0.51 | 0.51 | 0.21 | 0.46 | 0.26 | 0.12 | 0.06 | 0.17 | 0.08 | 0.09 |
| Current Ratio(x) | 1.19 | 1.42 | 1.46 | 1.69 | 1.58 | 1.81 | 1.86 | 1.97 | 1.62 | 1.89 | 1.78 |
| Quick Ratio(x) | 0.49 | 0.68 | 0.59 | 0.73 | 0.53 | 0.85 | 0.73 | 0.73 | 0.49 | 0.67 | 0.71 |
| Interest Cover(x) | 2.93 | 2.94 | 5.05 | 8.42 | 11.05 | 5.62 | 18.97 | 22.31 | 7.23 | 13.11 | 29.08 |
| Total Debt/Mcap(x) | 0.37 | 0.32 | 0.22 | 0.08 | 0.22 | 0.29 | 0.1 | 0.04 | 0.12 | 0.06 | 0.06 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 | 72.3 | 72.3 | 72.3 | 72.3 | 72.3 |
| FII | 5.19 | 4.42 | 4.32 | 4.36 | 5.43 | 5.13 | 4.49 | 4.66 | 4.51 | 4.46 |
| DII | 9.36 | 9.12 | 9.14 | 9.07 | 9.06 | 9.22 | 9.58 | 9.7 | 9.48 | 9.38 |
| Public | 13.3 | 14.31 | 14.39 | 14.41 | 13.36 | 13.35 | 13.63 | 13.34 | 13.71 | 13.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.14 | 2.14 | 2.14 | 2.14 | 2.14 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 |
| FII | 0.15 | 0.13 | 0.13 | 0.13 | 0.16 | 0.15 | 0.13 | 0.14 | 0.13 | 0.13 |
| DII | 0.28 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.28 | 0.28 | 0.28 | 0.27 |
| Public | 0.39 | 0.42 | 0.43 | 0.43 | 0.4 | 0.39 | 0.4 | 0.39 | 0.4 | 0.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.96 | 2.96 | 2.96 | 2.96 | 2.96 | 2.91 | 2.91 | 2.91 | 2.91 | 2.91 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
